摘要:
Hepatitis C virus inhibitors having the general Formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要:
Macrocyclic peptides are disclosed having the general formula: [I] , wherein R', R3, R3', R4, R6, X5 Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要:
Hepatitis C virus inhibitors having the general Formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要:
Macrocyclic isoquinoline are disclosed having the general formula: A compound of formula 1: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
摘要:
Macrocyclic isoquinoline are disclosed having the general formula: A compound of formula 1: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.